Drugmaker Dr Reddy's Laboratories posted an over seven-fold rise in first-quarter net profit on Thursday, handily beating market expectations, aided by the launch of a generic version of an opioid addiction drug.
Net profit came in at Rs 476 ($69.31 million) in the quarter ended June 30, compared with Rs 66.6 crore a year earlier, the company said.
Analysts on average had expected a net profit of Rs 298 crore, according to estimates compiled by Thomson Reuters.
($1 = Rs 68.6750)
(This story has not been edited by NDTV staff and is auto-generated from a syndicated feed.)
Get Breaking news, live coverage, and Latest News from India and around the world on NDTV.com. Catch all the Live TV action on NDTV 24x7 and NDTV India. Like us on Facebook or follow us on Twitter and Instagram for latest news and live news updates.